CHEMED CORP

Listed Company

CHECIK 0000019584NYSELarge AcceleratedServices-Home Health Care ServicesDelawareFY ends Dec 31

Period

FY 2025

Revenue

$2.53B

Net Income

$265.24M

Total Assets

$1.54B

Equity

$979.40M

Shares Out

13.27M

Op. Cash Flow

$388.27M

CHE$489.64+3.91% · past yearDBEQ Basic

Daily closing prices

Business

Chemed Corporation operates two reportable business segments: VITAS and Roto-Rooter. VITAS provides hospice and palliative care services to patients through physicians, nurses, home health aides, social workers, clergy and volunteers. Roto-Rooter provides plumbing, drain cleaning, excavation, water restoration and related services to residential and commercial customers. VITAS derives substantially all of its revenue from Medicare and Medicaid programs on a per-diem basis. Roto-Rooter operates through company-owned locations and franchises across the United States, competing in a fragmented market.

Summary from 10-K filed 2026-02-27

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Service revenues and sales (Note 2)	2,530	2,431	2,264	2,135	2,139
Cost of services provided and goods sold (excluding depreciation)	1,707	1,577	1,466	1,370	1,369
Selling, general and administrative expenses	417	424	395	359	367
Depreciation	55	53	51	49	49
Amortization	10	10	10	10	10
Other operating expenses (Note 20)	3	446,000	2	4	987,000
Total costs and expenses	2,192	2,065	1,924	1,791	1,796
Income from operations	338	366	341	343	343
Interest expense	−2	−2	−3	−5	−2
Other income - net (Note 10)	19	35	13	−9	9
Income before income taxes	356	399	350	330	350
Income taxes (Note 11)	−91	−97	−78	−80	−82
Net Income	265	302	273	250	269
Net Income (per share)	18.42	20.1	18.11	16.72	17.14
Average number of shares outstanding	14	15	15	15	16
Net Income (per share)	18.34	19.89	17.93	16.53	16.85
Average number of shares outstanding	14	15	15	15	16

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Cash and cash equivalents (Note 9)	75	178	264	74	33
Accounts receivable	183	171	182	139	137
Inventories	8	8	12	10	10
Prepaid income taxes	11	11	13	19	17
Prepaid expenses	27	26	30	30	33
Total current assets	303	395	501	273	230
Investments of deferred compensation plans held in trust (Notes 15 and 17)	140	131	106	93	99
Properties and equipment, at cost, less accumulated depreciation (Note 13)	206	201	204	200	194
Lease right of use asset (Note 14)	131	127	126	136	125
Identifiable intangible assets less accumulated amortization (Note 6)	83	92	90	100	108
Goodwill	667	667	585	581	579
Other assets (Note 12)	9	56	56	60	8
Total Assets	1,538	1,669	1,668	1,442	1,343
Accounts payable	64	44	64	42	73
Accrued insurance	62	57	59	59	56
Income taxes (Note 11)	3	8	7	—	41,000
Accrued compensation	58	92	88	87	96
Short-term lease liability (Note 14)	41	42	39	39	38
Other current liabilities (Note 21)	59	43	56	61	39
Total current liabilities	287	286	312	297	302
Deferred income taxes (Note 11)	19	26	30	39	23
Deferred compensation liabilities (Note 15)	136	126	104	92	99
Long-term lease liability (Note 14)	103	99	101	111	101
Other liabilities	13	13	13	12	10
Total Liabilities	559	550	560	643	719
Commitments and contingencies (Note 18)	—	—	—	—	—
Capital stock - authorized 80,000,000 shares $1 par; issued 37,594,676 shares (2024 - 37,422,348 shares)	38	37	37	37	37
Paid-in capital	1,592	1,484	1,341	1,150	1,044
Retained earnings	2,955	2,722	2,447	2,198	1,970
Treasury stock - 23,884,187 shares (2024 - 22,865,842 shares), at cost	−3,608	−3,127	−2,720	−2,588	−2,430
Deferred compensation payable in Company stock (Note 15)	2	2	2	2	2
Total Stockholders' Equity	979	1,119	1,108	799	623
Total Liabilities and Stockholders' Equity	1,538	1,669	1,668	1,442	1,343

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Depreciation and amortization	65	63	61	59	59
Stock option expense	33	32	30	26	23
Benefit for deferred income taxes	−6	−4	−8	15	2
Noncash portion of long-term incentive compensation	5	19	9	6	8
Litigation settlements	1	−6	2	—	—
Noncash directors' compensation	1	1	1	1	1
Amortization of debt issuance costs	321,000	321,000	580,000	342,000	306,000
(Increase)/decrease in accounts receivable	−12	11	−41	−2	−8
Decrease/(increase) in inventories	650,000	4	−2	−162,000	−3
(Increase)/decrease in prepaid expenses	−844,000	4	87,000	2	−7
Decrease in accounts payable and other current liabilities	−5	−9	−9	15	10
Change in current income taxes	−6	2	12	−996,000	−20
Net change in lease assets and liabilities	−806,000	−674,000	−1	1	−44,000
Decrease/(increase) in other assets	37	−26	−10	−46	−10
Increase in other liabilities	10	23	13	−3	12
Other sources	459,000	2	836,000	−26,000	1
Net cash provided by operating activities	388	417	330	310	309
Capital expenditures	−63	−50	−57	−57	−59
Proceeds from sale of fixed assets	5	3	640,000	2	904,000
Business combinations, net of cash acquired	−225,000	−97	−4	−4	—
Other uses	−888,000	−295,000	−434,000	−878,000	14,000
Net cash used by investing activities	−59	−144	−61	−59	−58
Purchases of treasury stock	−432	−361	−68	−115	−576
Dividends paid	−32	−27	−24	−22	−22
Proceeds from exercise of stock options	27	57	102	45	36
Change in cash overdraft payable	11	−16	16	−12	12
Capital stock surrendered to pay taxes on stock-based compensation	−9	−9	−10	−16	−15
Payments on other long-term debt	—	—	−98	−3	—
Other sources/(uses)	1	−2	490,000	−1	−165,000
Net cash used by financing activities	−433	−359	−80	−209	−381
(Decrease)/increase in cash and cash equivalents	−104	−86	190	41	−130

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro

Frequently asked questions

What is CHEMED CORP's CIK number?

CHEMED CORP's SEC CIK number is 0000019584 (19584). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.

Where can I find CHEMED CORP's SEC filings?

All of CHEMED CORP's EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.

When did CHEMED CORP last report earnings?

CHEMED CORP (CHE) most recently filed an earnings 8-K with the SEC on Apr 23, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0000019584-26-000010). This is CHEMED CORP's most recent earnings filing of record — not a forecast of its next earnings date.

What is CHEMED CORP's most recent earnings 8-K?

CHEMED CORP's latest earnings 8-K (Item 2.02) was filed Apr 23, 2026 under accession 0000019584-26-000010. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.

View CHEMED CORP's latest earnings 8-K →
Look up any company's CIK number →